614 related articles for article (PubMed ID: 33013894)
41. Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG
Köhler VK; Crescioli S; Fazekas-Singer J; Bax HJ; Hofer G; Pranger CL; Hufnagl K; Bianchini R; Flicker S; Keller W; Karagiannis SN; Jensen-Jarolim E
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784509
[TBL] [Abstract][Full Text] [Related]
42. Isolation of Mal d 1 and Api g 1 - specific recombinant antibodies from mouse IgG Fab fragment libraries - Mal d 1-specific antibody exhibits cross-reactivity against Bet v 1.
Haka J; Niemi MH; Iljin K; Reddy VS; Takkinen K; Laukkanen ML
BMC Biotechnol; 2015 May; 15():34. PubMed ID: 26013405
[TBL] [Abstract][Full Text] [Related]
43. Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen.
Son DY; Scheurer S; Hoffmann A; Haustein D; Vieths S
Eur J Nutr; 1999 Aug; 38(4):201-15. PubMed ID: 10502033
[TBL] [Abstract][Full Text] [Related]
44. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
Ferreira F; Hirtenlehner K; Jilek A; Godnik-Cvar J; Breiteneder H; Grimm R; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Breitenbach M; Rheinberger HJ; Ebner C
J Exp Med; 1996 Feb; 183(2):599-609. PubMed ID: 8627171
[TBL] [Abstract][Full Text] [Related]
45. IgE and allergen-specific immunotherapy-induced IgG
Groh N; von Loetzen CS; Subbarayal B; Möbs C; Vogel L; Hoffmann A; Fötisch K; Koutsouridou A; Randow S; Völker E; Seutter von Loetzen A; Rösch P; Vieths S; Pfützner W; Bohle B; Schiller D
Clin Exp Allergy; 2017 May; 47(5):693-703. PubMed ID: 27770477
[TBL] [Abstract][Full Text] [Related]
46. The role of IgG
Strobl MR; Demir H; Sánchez Acosta G; Drescher A; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2023 May; 151(5):1371-1378.e5. PubMed ID: 36657603
[TBL] [Abstract][Full Text] [Related]
47. The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
Smole U; Radauer C; Lengger N; Svoboda M; Rigby N; Bublin M; Gaier S; Hoffmann-Sommergruber K; Jensen-Jarolim E; Mechtcheriakova D; Breiteneder H
PLoS One; 2015; 10(1):e0117904. PubMed ID: 25635684
[TBL] [Abstract][Full Text] [Related]
48. Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1.
Vrtala S; Hirtenlehner K; Susani M; Akdis M; Kussebi F; Akdis CA; Blaser K; Hufnagl P; Binder BR; Politou A; Pastore A; Vangelista L; Sperr WR; Semper H; Valent P; Ebner C; Kraft D; Valenta R
FASEB J; 2001 Sep; 15(11):2045-7. PubMed ID: 11511511
[TBL] [Abstract][Full Text] [Related]
49. Birch pollen immunotherapy inhibits anaphylaxis to the cross-reactive apple allergen Mal d 1 in mice.
Utsch L; Logiantara A; Wallner M; Hofer H; van Ree R; van Rijt LS
Clin Exp Allergy; 2016 Nov; 46(11):1474-1483. PubMed ID: 27376790
[TBL] [Abstract][Full Text] [Related]
50. Molecular basis of pollen-related food allergy: identification of a second cross-reactive IgE epitope on Pru av 1, the major cherry (Prunus avium) allergen.
Wiche R; Gubesch M; König H; Fötisch K; Hoffmann A; Wangorsch A; Scheurer S; Vieths S
Biochem J; 2005 Jan; 385(Pt 1):319-27. PubMed ID: 15330760
[TBL] [Abstract][Full Text] [Related]
51. Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2.
Vrtala S; Mayer P; Ferreira F; Susani M; Sehon AH; Kraft D; Valenta R
J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):913-21. PubMed ID: 8939154
[TBL] [Abstract][Full Text] [Related]
52. Bet v 1--a Trojan horse for small ligands boosting allergic sensitization?
Asam C; Batista AL; Moraes AH; de Paula VS; Almeida FC; Aglas L; Kitzmüller C; Bohle B; Ebner C; Ferreira F; Wallner M; Valente AP
Clin Exp Allergy; 2014 Aug; 44(8):1083-93. PubMed ID: 24979350
[TBL] [Abstract][Full Text] [Related]
53. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
54. A sensitive assay for the detection of IgE bound to the major birch pollen allergen, Bet v 1, in the form of immune complexes.
Pree I; Reisinger J; Bohle B; Frantal S; Valenta R; Niederberger V
J Immunol Methods; 2009 Jun; 345(1-2):100-5. PubMed ID: 19376122
[TBL] [Abstract][Full Text] [Related]
55. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China.
Hao GD; Zheng YW; Wang ZX; Kong XA; Song ZJ; Lai XX; Spangfort MD
J Zhejiang Univ Sci B; 2016 May; 17(5):399-404. PubMed ID: 27143268
[TBL] [Abstract][Full Text] [Related]
56. Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE.
Reginald K; Eckl-Dorna J; Zafred D; Focke-Tejkl M; Lupinek C; Niederberger V; Keller W; Valenta R
Immunol Cell Biol; 2013 Feb; 91(2):167-72. PubMed ID: 23229638
[TBL] [Abstract][Full Text] [Related]
57. The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses.
Ejrnaes AM; Bodtger U; Larsen JN; Svenson M
Mol Immunol; 2004 Jul; 41(5):471-8. PubMed ID: 15183926
[TBL] [Abstract][Full Text] [Related]
58. The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization.
Orlandi A; Grasso F; Corinti S; Marinaro M; Bonura A; Boirivant M; Colombo P; Di Felice G
Clin Exp Allergy; 2004 Mar; 34(3):470-7. PubMed ID: 15005743
[TBL] [Abstract][Full Text] [Related]
59. Epitope grafting, re-creating a conformational Bet v 1 antibody epitope on the surface of the homologous apple allergen Mal d 1.
Holm J; Ferreras M; Ipsen H; Würtzen PA; Gajhede M; Larsen JN; Lund K; Spangfort MD
J Biol Chem; 2011 May; 286(20):17569-78. PubMed ID: 21454600
[TBL] [Abstract][Full Text] [Related]
60. A hypoallergenic vaccine obtained by tail-to-head restructuring of timothy grass pollen profilin, Phl p 12, for the treatment of cross-sensitization to profilin.
Westritschnig K; Linhart B; Focke-Tejkl M; Pavkov T; Keller W; Ball T; Mari A; Hartl A; Stöcklinger A; Scheiblhofer S; Thalhamer J; Ferreira F; Vieths S; Vogel L; Böhm A; Valent P; Valenta R
J Immunol; 2007 Dec; 179(11):7624-34. PubMed ID: 18025208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
